140 related articles for article (PubMed ID: 29061784)
1. BMI1 Inhibitors Down-regulate NOTCH Signaling and Suppress Proliferation of Acute Leukemia Cells.
Ohtaka M; Itoh M; Tohda S
Anticancer Res; 2017 Nov; 37(11):6047-6053. PubMed ID: 29061784
[TBL] [Abstract][Full Text] [Related]
2. The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells.
Mayr C; Wagner A; Loeffelberger M; Bruckner D; Jakab M; Berr F; Di Fazio P; Ocker M; Neureiter D; Pichler M; Kiesslich T
Oncotarget; 2016 Jan; 7(1):745-58. PubMed ID: 26623561
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation.
Srinivasan M; Bharali DJ; Sudha T; Khedr M; Guest I; Sell S; Glinsky GV; Mousa SA
Oncotarget; 2017 Jun; 8(24):38731-38742. PubMed ID: 28418883
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1.
Barbosa K; Deshpande A; Chen BR; Ghosh A; Sun Y; Dutta S; Weetall M; Dixon J; Armstrong SA; Bohlander SK; Deshpande AJ
Exp Hematol; 2019 Jun; 74():42-51.e3. PubMed ID: 31022428
[TBL] [Abstract][Full Text] [Related]
5. The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells.
Mourgues L; Imbert V; Nebout M; Colosetti P; Neffati Z; Lagadec P; Verhoeyen E; Peng C; Duprez E; Legros L; Rochet N; Maguer-Satta V; Nicolini FE; Mary D; Peyron JF
Leukemia; 2015 Oct; 29(10):1993-2002. PubMed ID: 25925206
[TBL] [Abstract][Full Text] [Related]
6. Gamma-secretase inhibitors suppress the growth of leukemia and lymphoma cells.
Kogoshi H; Sato T; Koyama T; Nara N; Tohda S
Oncol Rep; 2007 Jul; 18(1):77-80. PubMed ID: 17549349
[TBL] [Abstract][Full Text] [Related]
7. Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment.
Bolomsky A; Schlangen K; Schreiner W; Zojer N; Ludwig H
J Hematol Oncol; 2016 Mar; 9():17. PubMed ID: 26935956
[TBL] [Abstract][Full Text] [Related]
8. Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance.
Shahi MH; Farheen S; Mariyath MP; Castresana JS
Tumour Biol; 2016 Nov; 37(11):15107-15114. PubMed ID: 27662839
[TBL] [Abstract][Full Text] [Related]
9. Preclinical activity of the novel B-cell-specific Moloney murine leukemia virus integration site 1 inhibitor PTC-209 in acute myeloid leukemia: Implications for leukemia therapy.
Nishida Y; Maeda A; Chachad D; Ishizawa J; Qiu YH; Kornblau SM; Kimura S; Andreeff M; Kojima K
Cancer Sci; 2015 Dec; 106(12):1705-13. PubMed ID: 26450753
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of BMI1 induces autophagy-mediated necroptosis.
Dey A; Mustafi SB; Saha S; Kumar Dhar Dwivedi S; Mukherjee P; Bhattacharya R
Autophagy; 2016; 12(4):659-70. PubMed ID: 27050456
[TBL] [Abstract][Full Text] [Related]
11. A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells.
Dimri M; Kang M; Dimri GP
Oncotarget; 2016 Jun; 7(24):36220-36234. PubMed ID: 27105531
[TBL] [Abstract][Full Text] [Related]
12. Bmi1 regulates murine intestinal stem cell proliferation and self-renewal downstream of Notch.
López-Arribillaga E; Rodilla V; Pellegrinet L; Guiu J; Iglesias M; Roman AC; Gutarra S; González S; Muñoz-Cánoves P; Fernández-Salguero P; Radtke F; Bigas A; Espinosa L
Development; 2015 Jan; 142(1):41-50. PubMed ID: 25480918
[TBL] [Abstract][Full Text] [Related]
13. CDKN2A-independent role of BMI1 in promoting growth and survival of Ph+ acute lymphoblastic leukemia.
Mariani SA; Minieri V; De Dominici M; Iacobucci I; Peterson LF; Calabretta B
Leukemia; 2016 Aug; 30(8):1682-90. PubMed ID: 27125204
[TBL] [Abstract][Full Text] [Related]
14. BMI1 promotes steroidogenesis through maintaining redox homeostasis in mouse MLTC-1 and primary Leydig cells.
Gao T; Lin M; Shao B; Zhou Q; Wang Y; Chen X; Zhao D; Dai X; Shen C; Cheng H; Yang S; Li H; Zheng B; Zhong X; Yu J; Chen L; Huang X
Cell Cycle; 2020 Aug; 19(15):1884-1898. PubMed ID: 32594840
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Regulation of Bmi1 by Ubiquitination and Proteasomal Degradation Inhibit Bcl-2 in Acute Myeloid Leukemia.
Kushwaha AC; Mohanbhai SJ; Sardoiwala MN; Sood A; Karmakar S; Roy Choudhury S
ACS Appl Mater Interfaces; 2020 Jun; 12(23):25633-25644. PubMed ID: 32453568
[TBL] [Abstract][Full Text] [Related]
16. NOTCH knockdown affects the proliferation and mTOR signaling of leukemia cells.
Okuhashi Y; Itoh M; Nara N; Tohda S
Anticancer Res; 2013 Oct; 33(10):4293-8. PubMed ID: 24122995
[TBL] [Abstract][Full Text] [Related]
17. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling.
Suwanjunee S; Wongchana W; Palaga T
Anticancer Drugs; 2008 Jun; 19(5):477-86. PubMed ID: 18418214
[TBL] [Abstract][Full Text] [Related]
19. Effect of Twist and Bmi1 on intraductal papillary mucinous neoplasm of the pancreas.
Ishikawa D; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Yamada S; Miyake H
J Gastroenterol Hepatol; 2014 Dec; 29(12):2032-7. PubMed ID: 24909638
[TBL] [Abstract][Full Text] [Related]
20. A genome-wide enrichment screen identifies NUMA1-loss as a resistance mechanism against mitotic cell-death induced by BMI1 inhibition.
Gisler S; Maia ARR; Chandrasekaran G; Kopparam J; van Lohuizen M
PLoS One; 2020; 15(4):e0227592. PubMed ID: 32343689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
